CVR 44240238Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 11 Aug 2023
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Amalus Therapeutics Denmark ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexGross profit
-313.2K
DKK, annual report 2024
Result
-408.8K
DKK, annual report 2024
Equity
-368.8K
DKK, annual report 2024
Amalus Therapeutics BV100% of capital and votes, until 26 Aug 2026
Bart Ivan M. Romanuntil 16 Dec 2025
Christian Victor O. Stevensuntil 16 Dec 2025
Equity was negative at 31 Dec 2024: -368.8K DKK. Dandex estimate, computed 28 Oct 2026.
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
100% of capital and votes11 Aug 2023 to 26 Aug 2026
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
11 Aug 2023 to 28 Oct 2026.
| Metric | 2024 |
|---|---|
| Gross profit | -313 |
| Operating profit | -313 |
| Result for the year | -409 |
| Equity | -369 |
| Total assets | 4,034 |
| Employees (average) | 0 |
| Credit metrics (Dandex calculations) | |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -415note 1 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | -4,029note 1 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group. 2024 covers 17 months (11 Aug 2023 to 31 Dec 2024).
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2024
11 Aug 2023 to 31 Dec 2024, published 15 Apr 2025
Amalus Therapeutics Denmark ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 25 Dec 2026.
1 registered in CVR.
P-number 1029556241Østbanegade 123, 2100 København Ø
